Newsroom | 100639 results

DURHAM, N.C.--(BUSINESS WIRE)--Target RWE and NoviSci, two leaders in evidence generation, today announced they will rebrand as Pedestal Health and Headwater Science. These two distinct companies will work to build a modern evidence-generation engine for life sciences organizations, navigating the most complex and consequential research challenges. Pedestal Health (formerly Target RWE) is a full-service evidence generation partner for life sciences organizations. The company delivers scientific...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood pressure in adults who are not adequately controlled. There are 1.4 billion people worldwide living with hypertension.1 In the US, approximately 50% of patients living with hypertension who are already taking multiple antihypertensive me...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced its financial results for the first quarter ended March 31, 2026, and provided a business update. Gossamer Bio and the Chiesi Group are jointly developing seralutinib under a...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parabilis Medicines today announced a strategic research collaboration with Regeneron Pharmaceuticals, Inc. to discover and develop multiple therapeutic candidates based on Parabilis’s Helicon™ peptide platform, with a particular focus on Antibody-Helicon™ Conjugates (AHCs), a novel class of therapeutics designed to target challenging and historically “undruggable” targets. Helicons are stabilized, cell-penetrant alpha-helical peptides designed to engage intra...

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: Goldman Sachs 47th Annual Global Healthcare Conference - Miami Beach, June 8, 2026, Fireside Chat Time: 8:40 am Eastern Time Truist Securities MedTech Conference - Boston, June 16, 2026, 1x1 Meetings Only Interested parties can access the live and archived webcast of the Goldman Sachs fireside...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck's TroFuse-005 Trial Evaluating Sac-TMT Met Primary Endpoints of OS and PFS in Certain Patients With Advanced or Recurrent Endometrial Cancer...

LONDON--(BUSINESS WIRE)--Prokarium, a clinical-stage biopharmaceutical company pioneering bacterial immunotherapies for the treatment of solid tumours, today announced safety and antitumour efficacy results from an interim review of the ongoing Phase 1/1b PARADIGM-1 trial of ZH9 in non-muscle invasive bladder cancer (NMIBC) patients. These data were shared via an oral podium presentation at the American Urology Association (AUA26) Annual Meeting. Prokarium CMO, Dr Josefin-Beate Holz said “These...

LONDRES, MUNICH et ZURICH--(BUSINESS WIRE)--Le ministère coréen des Sciences et des TIC (MSIT) organisera en juin le Salon mondial de l’emploi postdoctoral InnoCORE 2026, avec des événements prévus à Londres, Munich et Zurich. Cette initiative fait suite au lancement réussi de l’événement à New York, Boston et dans la Silicon Valley en mai 2026. Organisé par le MSIT en collaboration avec le KAIST, le GIST, le DGIST et l’UNIST, ce salon mettra en relation d’excellents chercheurs postdoctoraux du...

LONDON & MÜNCHEN & ZÜRICH--(BUSINESS WIRE)--Das koreanische Ministerium für Wissenschaft und IKT (MSIT) veranstaltet im Juni die InnoCORE Global Postdoctoral Job Fair 2026 mit bevorstehenden Veranstaltungen in London, München und Zürich. Dies folgt auf den erfolgreichen Start der Initiative im Mai 2026 in New York, Boston und im Silicon Valley. Die vom MSIT gemeinsam mit KAIST, GIST, DGIST und UNIST organisierte Jobmesse wird herausragende Postdoktoranden aus aller Welt mit führenden koreanisch...

LONDON & MUNICH & ZURICH--(BUSINESS WIRE)--The Korean government hosts the 2026 InnoCORE Global Postdoctoral Job Fair in London, Munich, and Zurich....